Lake Street Analyst Maintains Buy Rating on Evolv Technologies Holdings

Evolv Tech released FY2025 Q3 earnings on November 13 After-Market EST, actual revenue USD 42.85 M (forecast USD 33.68 M), actual EPS USD -0.0103 (forecast USD -0.07)

Evolv Tech released FY2025 9 Months Earnings on November 13 After-Market EST, actual revenue USD 107.4 M, actual EPS USD -0.2708

Evolv Tech to Release FY2025 Q3 Earnings on November 13 After-Market EST, Forecast Revenue USD 33.68 M, EPS USD -0.07

Latimore Analyst Gives Strong Buy Rating to Evolv Technologies Holdings

Analyst Hamblin Recommends Evolv Technologies Holdings Stock

Cantor Fitzgerald Raises Target Price on Evolv Technologies

Evolv Tech released FY2025 Q2 earnings on August 14 After-Market EST, actual revenue USD 32.54 M (forecast USD 30.95 M), actual EPS USD -0.25 (forecast USD -0.0775)

Evolv Tech released FY2025 Semi-Annual earnings on August 14 After-Market (EST), actual revenue USD 64.55M, actual EPS USD -0.26

Evolv Tech to Release FY2025 Q2 Earnings on August 14 After-Market EST, Forecast Revenue USD 30.95 M, EPS USD -0.0775

Evolv Technologies Holdings Inc. Submits an Amendment to Switch Registration Form from S-3 to S-1

Evolv Technologies Holds Annual Shareholders Meeting

Bronstein Investigating Potential Misconduct at Evolv Technologies

Bronstein Investigating Evolv's Improper Conduct

Nuveen Reduces Holdings in Evolv Technologies

Evolv Technologies Hits 52-Week High with Surpassing Q4 Earnings

Evolv Technologies Holdings Inc reports improved loss per share and revenue growth

Northland Raises Rating for Evolv Technologies

Lake Street Maintains Evolv Technologies' Rating, Raises Target Price to $5.50

Evolv Tech released FY2025 Q1 earnings on May 20 After-Market EST, actual revenue USD 32.01 M (forecast USD 27.99 M), actual EPS USD -0.0105 (forecast USD -0.09)

EVLV 260116 10 Call

AdvisorShares MSOS 2x Daily ETF

cbdMD

Tryhard

Roundhill Cannabis ETF

Neo-Concept

Amplify Seymour Cannabis ETF

AdvisorShares Pure US Cannabis ETF

Canopy Growth

RYTHM

Tilray Brands

TNYA

EVLV

AARD

Top Wall Street analysts have given 'Strong Buy' ratings to three stocks: Tenaya Therapeutics (TNYA), Evolv Technologies (EVLV), and Aardvark Therapeutics (AARD). Tenaya Therapeutics focuses on gene and cell therapies for heart diseases, with an implied upside of 826.5%. Evolv Technologies develops AI tools for weapon detection, with an implied upside of 44.44%. Aardvark Therapeutics targets obesity treatments, with an implied upside of 101.35%.

Tip Ranks

Tenaya Therapeutics

Evolv Tech

Aardvark Therapeutics

3 'Strong Buy' Stocks to Buy Today, 12/12/2025, According to Top Analysts

Lake Street analyst Eric Martinuzzi reiterated a Buy rating for Evolv Technologies Holdings with a $10 price target. Martinuzzi, a 4-star analyst, has a 6.3% average return and a 43.42% success rate. Evolv also received a Buy rating from Craig-Hallum's Jeremy Hamblin, while TR | OpenAI – 4o maintained a Hold rating. Martinuzzi covers the Technology sector, focusing on stocks like Par Technology and Quantum.

Lake Street Sticks to Its Buy Rating for Evolv Technologies Holdings (EVLV)

Evolv Technologies Holdings' Chief Revenue Officer, Robert E Marshall, purchased 7,000 shares valued at $42,420. The company reported strong Q3 earnings with 57% revenue growth, leading to a stock price target increase from $9 to $10. Despite strategic advancements, challenges include declining gross margins and reliance on one-time revenue. Evolv plans a direct distribution model to boost recurring revenue. Spark rates EVLV as Neutral due to profitability and cash flow issues, despite positive guidance and partnerships.

Top Executive Makes Bold Move with Major Stock Purchase

Robert E. Marshall, Chief Revenue Officer of Evolv Technologies Holdings Inc., has acquired common shares of the company. This event was reported via EDGAR by the U.S. Securities and Exchange Commission on November 25, 2025. The information is provided by Public Technologies using AI and is not financial advice.

Reuters

Chief Revenue Officer Robert E. Marshall Reports Acquisition of Evolv Technologies Holdings Inc. Common Shares

John Kedzierski, CEO of Evolv Technologies Holdings Inc., has acquired common shares of the company. This information was published via EDGAR by the U.S. SEC on November 24, 2025. The news is generated by Public Technologies using AI and is for informational purposes only.

Evolv Technologies CEO John Kedzierski Reports Acquisition of Common Shares

Kevin M. Charlton, Director of Evolv Technologies Holdings Inc., has acquired common shares of the company. This acquisition was reported through EDGAR by the U.S. Securities and Exchange Commission on November 21, 2025. The information is provided by Public Technologies using AI and is not financial advice.

Director Kevin M. Charlton Acquires Common Shares of Evolv Technologies Holdings Inc

Director Richard A. Shapiro has acquired common shares of Evolv Technologies Holdings Inc. The full filing is available via EDGAR, Ref. ID: 0001648814-25-000004, dated November 20, 2025.

Director Richard A. Shapiro Reports Acquisition of Evolv Technologies Holdings Inc. Common Shares

Michael Ellenbogen, Director of Evolv Technologies Holdings Inc., reported the sale of common shares of the company. The filing is available via EDGAR, the SEC's system. This AI-generated news is for informational purposes and not financial advice.

Director Michael Ellenbogen Reports Sale of Evolv Technologies Holdings Inc. Common Shares

Evolv Technologies reported strong Q3 revenue growth of 57% year-over-year, driven by new customer acquisition and expanded deployments. The company achieved positive adjusted EBITDA for the fourth consecutive quarter, with margins at 12%. Key highlights include a record customer contract and a strategic partnership with Plexus. However, challenges include a decline in adjusted gross margins and reliance on one-time revenue sources. Forward guidance for 2025 and 2026 suggests a focus on enhancing recurring revenue and profitability.

Evolv Technologies Q3 Earnings: Growth Amid Challenges

Analyst Shaul Eyal of TD Cowen reiterated a Buy rating for Evolv Technologies Holdings, maintaining a $10 price target. The company showed strong Q3 2025 results with a 57% revenue increase, driven by a major contract and strong demand. Evolv's AI-powered product developments and strategic partnerships bolster its growth outlook. Lake Street also maintained a Buy rating with a $9 target. Eyal, with a 25.5% average return, covers the Technology sector.

Evolv Technologies Holdings: Strong Performance and Future Growth Potential Justify Buy Rating

Evolv Technologies Holdings Inc. reported a 57% increase in Q3 2025 revenue to $42.9 million. Product revenue was $9.2 million, and subscription revenue reached $22.7 million. The net loss was $1.8 million with a (4)% net profit margin. Adjusted EBITDA was $5.1 million, with a 12% margin. Annual recurring revenue grew 25% to $117.2 million. The company raised its full-year 2025 revenue outlook to $142-$145 million, a 37%-40% increase from the previous year.

Evolv Technologies Holdings Q3 Revenue Rises 57% to $42.9 Million

FANG

Top Wall Street analysts have given Strong Buy ratings to Diamondback Energy (FANG) and Evolv Technologies (EVLV). Diamondback Energy, a U.S. shale producer, has a price target of $162, implying a 25.71% upside. Evolv Technologies, a security tech firm, has a price target of $9, implying a 42.55% upside. These recommendations are based on recent analyst updates and are highlighted by TipRanks' Analyst Top Stocks tool.

Diamondback Energy

2 Best Stocks to Buy Now, 11/13/2025, According to Top Analysts

Evolv Technologies Holdings shares are trading higher after the company reported better-than-expected Q3 financial results.

benzinga_article